Civil society letter calls for European Parliament to support global access to medical tools


Flexibilities Navigator: An evermore valuable resource


Licensing of health technologies: New Report

WTO institutionally unfit for the purpose of delivering sustainable solutions

Introducing the TRIPS Flexibilities Navigator

HAI Statement on Tentative Agreement on TRIPS and COVID-19


Getting Hack to Reality

A Pandemic Response Lacking Moral Leadership

MPs and MEPs Call for TRIPS Waiver

Challenging the IP Protection Framework

Over 100 MEPs call for a TRIPS Waiver


HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond


A Momentous Week for Access to Medicines


Staff Spotlight: Jaume Vidal

Medicijnen: de link met de maatschappij

Open Science for Health: Shaping the New Framework Programme


EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

New Dutch Government Must Ensure Transparency to Control Medicine Prices

Staff Spotlight: Tim Reed


Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69


Successful week of advocacy for HAI delegation at 68th World Health Assembly

The EU-US Trade Deal Could Leave Europeans Sick


Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply

Bayer CEO's callous comments highlight failure of current biomedical innovation model


Report exposes how Big Pharma has hijacked EU-India trade deal